FNCHQ (FNCHQ) Stock Price & Analysis
FNCHQ (FNCHQ) rose 0.00% to USD 10 as of July 26, 2026 at 13:38 UTC, according to Nexqual real-time market data.
FNCHQ last closed at USD 10; the session ranged USD 7–7.75 on volume of 600 shares. Market capitalization is —, with a 52-week range of USD 2–16.1 (PNK). Source: Nexqual, July 26, 2026 at 13:38 UTC.
Key Statistics (as of July 26, 2026 at 13:38 UTC)
| Price | USD 10 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10 |
| Open | USD 10 |
| Day Range | USD 7 – 7.75 |
| 52-Week Range | USD 2 – 16.1 |
| Volume | 600 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (FNCHQ)
Nexqual's technical model rates FNCHQ "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 26, 2026 at 13:38 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 58.66 (neutral) |
| vs SMA50 | Above (USD 8.79) |
| MACD | 0.35 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CNTB | Connect Biopharma Holdings Limi | USD 2.14 | ▼ 2.73% |
| NEXI | NexImmune, Inc. | USD 0 | ▲ 0% |
| DSGN | Design Therapeutics, Inc. | USD 11.78 | ▲ 0% |
| HOWL | Werewolf Therapeutics, Inc. | USD 0.43 | ▲ 16.99% |
| CGEM | Cullinan Therapeutics, Inc. | USD 17.1 | ▼ 3.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 13:38 UTC. This page is informational and not investment advice.